超增强剂驱动的EFNA1通过FOSL2-Src/AKT/STAT3轴推动宫癌的瘤进展
Shu-Qiang Liu1,2,3, Xi-Xi Cheng1,3, Shuai He1,3
1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
The Journal of clinical investigation
|February 18, 2025
概括
超级增强剂通过调节EFNA1表达来驱动子宫癌 (CC). 针对FOSL2-EFNA1-EphA2通路为CC患者提供了新的治疗策略.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 超级增强剂 (SE) 在癌症中放大瘤基因表达.
- 在宫癌 (CC) 中SEs的作用在很大程度上是未知的.
研究的目的:
- 为了研究宫癌的SE景观.
- 为了确定新的SE及其驱动CC进展的基因.
主要方法:
- 结合瘤和正常组织的综合表观基因和转录基因分析.
- 对转录因子结合 (FOSL2) 和表观遗传修饰 (H3K27ac) 的分析.
- 功能性检测包括敲击,细胞增殖,迁移和体内瘤生长研究.
主要成果:
- 在EFNA1位点确定了一种特定于瘤的SE,该SE驱动了CC中的EFNA1表达.
- FOSL2与EFNA1 SE结合,规范其活动.
- 过度表达EFNA1与患者的不良结果相关,并促进CC细胞的增殖,迁移和瘤生长.
- 通过与EphA2的相互作用,EFNA1激活了Src/AKT/STAT3通路.
结论:
- 乳腺癌在宫癌的进展中起着至关重要的作用.
- FOSL2-EFNA1-EphA2-Src/AKT/STAT3轴是CC瘤发生的一个关键驱动因素.
- 这一途径为宫癌提供了潜在的预后和治疗标.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K


